Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

Clinical trial NCT06165900 · RECRUITING

Trial details

NCT number: NCT06165900
Sponsor: Shengjing Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stereotactic Radiotherapy Immunotherapy Breast Cancer

Start date: 2023-09-26
Primary completion: 2025-12-15
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.